Cantor Fitzgerald


Progenics Pharmaceuticals, Inc. (PGNX) Delay in NDA Filing Dose Not Reflect an Issue with Azedra Drug: Cantor

Commercial Revenues Are Likely in 2018 Despite Modest Delay in Filing

Teva Pharmaceutical Industries Ltd’s (ADR) (TEVA) AUSTEDO Wins Key FDA Approval To Corner TD Market

TEVA’s Brand Drug Portfolio and Pipeline Are Undervalued, Says Analyst

Is There Light at the End of the Tunnel for Snap Inc?

Snap Gaining 40.8% Share of US Social Network Users, as per eMarketer’s newest projections

Netflix, Inc. (NFLX) International Subscription Potential Points to Growth Opportunity

Cantor Fitzgerald analyst Kip Paulson conducted a Broadband Households (BB HH) penetration analysis on Netflix, Inc. (NASDAQ:NFLX), which resulted in encouragingĀ findings for the …

Cantor Weighs in on eBay Inc (EBAY) and Exponent, Inc. (EXPO) Following 3Q Earnings

As the earnings rollercoaster continues, Cantor Fitzgerald analysts are chiming in with divided perspectives on eBay Inc (NASDAQ:EBAY) and Exponent, Inc. (NASDAQ:EXPO).

Here’s Why Analysts Are Divided on Advanced Micro Devices, Inc. (AMD) and International Business Machines Corp. (IBM)

Analysts from Canaccord and Cantor Fitzgerald delve into semi-conductor giant Advanced Micro Devices, Inc. (NASDAQ:AMD) and computing giant International Business Machines Corp.

Analysts Chime in on Two Collapsing Biotech Stocks: Mast Therapeutics Inc (MSTX) and Mirna Therapeutics Inc (MIRN)

The biotech world is sounding the alarm on Mast Therapeutics Inc (NYSEMKT:MSTX) and Mirna Therapeutics Inc (NASDAQ:MIRN) after MSTX now has a Phase …

Cantor Chimes in on GW Pharmaceuticals PLC- ADR (GWPH) Amid Potential Suitors Circling

A recent article by Reuters indicates that GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has made the strategic decision to hire an investment bank as …

Biotech Beat: All Eyes On Relypsa Inc (RLYP) And EXACT Sciences Corporation (EXAS)

Both Relypsa Inc (NASDAQ:RLYP) and EXACT Sciences Corporation (NASDAQ:EXAS) received good news about their flagship products this week. Relypsa announced May prescription data …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts